OTCMKTS:CVLB - Conversion Labs Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $0.15 0.00 (0.00 %) (As of 05/26/2019 08:55 AM ET)Previous Close$0.15Today's Range$0.1430 - $0.1552-Week Range$0.1150 - $0.34Volume7,000 shsAverage Volume24,027 shsMarket Capitalization$7.03 millionP/E RatioN/ADividend YieldN/ABeta0.93 ProfileChartEarningsInsider TradesHeadlinesSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Conversion Labs, Inc., an Internet-based direct response marketing company, licenses, acquires, creates, and sells various products to consumers worldwide. Its products include Shapiro MD, a shampoo, conditioner, and leave-in foamer for thicker fuller hair; iNR Wellness MD, a nutritional supplement for immune support; and PDF Simpli, a PDF conversion software. The company sells its products through technology infrastructure and relationships with agencies, third party marketers, and online advertising platforms, as well as through its Websites inrwellness.com and shapiromd.com. The company was formerly known as Immudyne, Inc. and changed its name to Conversion Labs, Inc. in June 2018. Conversion Labs, Inc. was incorporated in 1987 and is based in New York, New York. Receive CVLB News and Ratings via Email Sign-up to receive the latest news and ratings for CVLB and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Miscellaneous manufacturing industries Sub-IndustryN/A SectorConsumer Staples Current SymbolOTCMKTS:CVLB Previous Symbol CUSIPN/A CIKN/A Webhttp://www.conversionlabs.com/ Phone866-351-5907Debt Debt-to-Equity Ratio0.14 Current Ratio0.73 Quick Ratio0.35Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$8.32 million Price / Sales0.85 Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net Income$-1,240,000.00 Net Margins-27.55% Return on Equity-201.80% Return on Assets-79.97%Miscellaneous Employees16 Outstanding Shares46,882,000Market Cap$7.03 million Next Earnings Date5/28/2019 (Estimated) OptionableNot Optionable Conversion Labs (OTCMKTS:CVLB) Frequently Asked Questions What is Conversion Labs' stock symbol? Conversion Labs trades on the OTCMKTS under the ticker symbol "CVLB." When is Conversion Labs' next earnings date? Conversion Labs is scheduled to release their next quarterly earnings announcement on Tuesday, May 28th 2019. View Earnings Estimates for Conversion Labs. Has Conversion Labs been receiving favorable news coverage? Headlines about CVLB stock have trended negative recently, according to InfoTrie Sentiment Analysis. The research firm identifies negative and positive press coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Conversion Labs earned a media sentiment score of -2.0 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 8.0 out of 10, indicating that recent press coverage is very likely to have an effect on the stock's share price in the next several days. Who are some of Conversion Labs' key competitors? Some companies that are related to Conversion Labs include Summer Infant (SUMR), Sigma Labs (SGLB), Trans-Lux (TNLX), Dais Analytic (DLYT), China Gengsheng Minerals (CHGS) and Kid Brands (KIDBQ). What other stocks do shareholders of Conversion Labs own? Based on aggregate information from My MarketBeat watchlists, some companies that other Conversion Labs investors own include AXT (AXTI), Icahn Enterprises (IEP), Lam Research (LRCX), Mellanox Technologies (MLNX), Skyworks Solutions (SWKS), Viper Energy Partners (VNOM), Brookfield Infrastructure Partners (BIP), BP (BP), BP Prudhoe Bay Royalty Trust (BPT) and Blackstone Mortgage Trust (BXMT). Who are Conversion Labs' key executives? Conversion Labs' management team includes the folowing people: Mr. Justin Schreiber, CEO, Pres & Director (Age 36)Mr. Stefan Galluppi, COO, Chief Technology Officer & Director (Age 32)Dr. Joseph V. DiTrolio, Chief Medical Officer of North America & Director (Age 68)Mr. Robert Kalkstein, Advisor to the CEO (Age 37)Mr. Sean Fitzpatrick, Chief Acquisition Officer (Age 36) How do I buy shares of Conversion Labs? Shares of CVLB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Conversion Labs' stock price today? One share of CVLB stock can currently be purchased for approximately $0.15. How big of a company is Conversion Labs? Conversion Labs has a market capitalization of $7.03 million and generates $8.32 million in revenue each year. Conversion Labs employs 16 workers across the globe. What is Conversion Labs' official website? The official website for Conversion Labs is http://www.conversionlabs.com/. How can I contact Conversion Labs? Conversion Labs' mailing address is 800 THIRD AVENUE SUITE 2800, NEW YORK NY, 10022. The company can be reached via phone at 866-351-5907 or via email at ir.conversionlabs.com. MarketBeat Community Rating for Conversion Labs (OTCMKTS CVLB)Community Ranking: 2.5 out of 5 ( )Outperform Votes: 69 (Vote Outperform)Underperform Votes: 68 (Vote Underperform)Total Votes: 137MarketBeat's community ratings are surveys of what our community members think about Conversion Labs and other stocks. Vote "Outperform" if you believe CVLB will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CVLB will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 5/26/2019 by MarketBeat.com StaffFeatured Article: What is the price-to-earnings growth (PEG) ratio? Receive Analysts' Upgrades and Downgrades Daily Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.